89 related articles for article (PubMed ID: 16725144)
1. SiRNA targeting SHP-1 accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Maeda T; Makino N
Atherosclerosis; 2007 Mar; 191(1):33-9. PubMed ID: 16725144
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Makino N
Circulation; 2004 Feb; 109(6):797-802. PubMed ID: 14970118
[TBL] [Abstract][Full Text] [Related]
3. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
4. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
[TBL] [Abstract][Full Text] [Related]
5. A protein tyrosine phosphatase inhibitor accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Makino N
J Cardiovasc Pharmacol; 2004 Oct; 44(4):460-5. PubMed ID: 15454854
[TBL] [Abstract][Full Text] [Related]
6. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end product Nε-carboxymethyllysine induces endothelial cell injury: the involvement of SHP-1-regulated VEGFR-2 dephosphorylation.
Liu SH; Sheu WH; Lee MR; Lee WJ; Yi YC; Yang TJ; Jen JF; Pan HC; Shen CC; Chen WB; Tien HR; Sheu ML
J Pathol; 2013 Jun; 230(2):215-27. PubMed ID: 22553146
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
9. RNA interference targeting SHP-1 attenuates myocardial infarction in rats.
Sugano M; Tsuchida K; Hata T; Makino N
FASEB J; 2005 Dec; 19(14):2054-6. PubMed ID: 16223786
[TBL] [Abstract][Full Text] [Related]
10. Delivery of small interfering RNA for inhibition of endothelial cell apoptosis by hypoxia and serum deprivation.
Cho SW; Hartle L; Son SM; Yang F; Goldberg M; Xu Q; Langer R; Anderson DG
Biochem Biophys Res Commun; 2008 Nov; 376(1):158-63. PubMed ID: 18765230
[TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
13. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis.
Singh KK; Shukla PC; Quan A; Al-Omran M; Lovren F; Pan Y; Brezden-Masley C; Ingram AJ; Stanford WL; Teoh H; Verma S
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):949-960.e4. PubMed ID: 23415688
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
16. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
[TBL] [Abstract][Full Text] [Related]
17. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.
Tepeköylü C; Wang FS; Kozaryn R; Albrecht-Schgoer K; Theurl M; Schaden W; Ke HJ; Yang Y; Kirchmair R; Grimm M; Wang CJ; Holfeld J
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):971-8. PubMed ID: 23395097
[TBL] [Abstract][Full Text] [Related]
18. Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb.
Croteau L; Mercier C; Fafard-Couture É; Nadeau A; Robillard S; Breton V; Guay A; Lizotte F; Despatis MA; Geraldes P
Diab Vasc Dis Res; 2021; 18(2):1479164121999033. PubMed ID: 33722087
[TBL] [Abstract][Full Text] [Related]
19. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
20. Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier.
Kim D; Hong J; Moon HH; Nam HY; Mok H; Jeong JH; Kim SW; Choi D; Kim SH
J Control Release; 2013 Jun; 168(2):125-34. PubMed ID: 23500061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
